five

Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers

收藏
NIAID Data Ecosystem2026-03-13 收录
下载链接:
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2379791
下载链接
链接失效反馈
官方服务:
资源简介:
This is a Phase I/Ib study in which the safety of the combination therapy of RMC-4630 and LY3214996 in the treatment of KRAS mutant cancers will be studied.
创建时间:
2022-03-15
二维码
社区交流群
二维码
科研交流群
商业服务